Bisacodyl Export Market Intelligence: India's 240 Suppliers Shipping to 108 Countries — TransData Nexus 2026

Q: Who are the top bisacodyl exporters from India?

The top bisacodyl exporters from India are: 1. DR.REDDY'S LABORATORIES LTD — $2.0M (22.9% market share); 2. IND SWIFT LIMITED — $760.7K (8.8% market share); 3. BLISS GVS PHARMA LIMITED — $712.9K (8.3% market share); 4. DR REDDYS LABORATORIES LIMITED — $458.7K (5.3% market share); 5. MEDREICH LIMITED — $399.9K (4.6% market share). Together they account for 50.0% of India's total bisacodyl export value.

Q: What is the total export value of bisacodyl from India?

The total export value of bisacodyl from India is $8.6M USD, recorded across 1,294 shipment transactions from 240 active exporters to 108 destination countries. The average shipment value is $6.7K.

Q: Which countries import bisacodyl from India?

India exports bisacodyl to 108 countries worldwide. The top importing countries are: UNITED KINGDOM (48.4% share, $4.2M), UNITED STATES (9.9% share, $856.6K), SRI LANKA (4.7% share, $409.0K), SOUTH AFRICA (3.7% share, $317.8K), MYANMAR (3.4% share, $294.7K). These five markets account for 70.2% of total export value.

Q: What is the HS code for bisacodyl exports from India?

The primary HS code for bisacodyl exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of bisacodyl exports from India?

The average unit price for bisacodyl exports from India is $5.76 USD per unit, with prices ranging from $0.00 to $1609.87 depending on formulation, packaging, and order volume. The total market is valued at $8.6M across 1,294 shipments.

Q: Which ports handle bisacodyl exports from India?

The primary ports for bisacodyl exports from India are SAHAR AIR CARGO ACC (INBOM4) (13.0% of shipments), NHAVA SHEVA SEA (INNSA1) (12.3% of shipments), SAHAR AIR (11.7% of shipments), JNPT/ NHAVA SHEVA SEA (5.7% of shipments), HYDERABAD ICD (4.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of bisacodyl?

India is one of the world's leading exporters of bisacodyl due to its large base of 240 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports bisacodyl to 108 countries, demonstrating 55% global market coverage.

Q: What certifications do Indian bisacodyl exporters need?

Indian bisacodyl exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import bisacodyl from India?

There are 415 registered buyers importing bisacodyl from India, spread across 108 countries. The repeat buyer rate is 50.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top bisacodyl supplier from India?

DR.REDDY'S LABORATORIES LTD is the leading bisacodyl exporter from India with a market share of 22.9% and total export value of $2.0M across 78 shipments. The top 5 suppliers together control 50.0% of total export value.

Suresh Sormare

Bisacodyl

India Pharmaceutical Trade Intelligence

$8.6M240 Suppliers108 CountriesHS 30049099

ExportsIndia → UNITED KINGDOM48.4%India → UNITED STATES9.9%

ImportsGERMANY → India$362 JAPAN → India$169

Bisacodyl Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Bisacodyl to the World

Between 2022 and 2026, India exported $8.6M worth of bisacodyl across 1,294 verified shipments to 108 countries — covering 55% of world markets in the Gastrointestinal segment. The largest destination is UNITED KINGDOM (48.4%). DR.REDDY'S LABORATORIES LTD leads with a 22.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Bisacodyl export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Bisacodyl export data snapshot — $8.6M · 240 exporters · 108 countriesTransData Nexus · Indian Customs Data

Top Bisacodyl Exporters from India

240 active exporters · Ranked by export value

View all 240 →

Top Bisacodyl Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	DR.REDDY'S LABORATORIES LTD	$2.0M	78	1	22.9%
2	IND SWIFT LIMITED

Top Countries Importing Bisacodyl from India

108 destination markets · Ranked by import value

All 108 countries →

Top Countries Importing Bisacodyl from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED KINGDOM	$4.2M	48.4%
2	UNITED STATES	$856.6K	9.9%
3	SRI LANKA	$409.0K	4.7%
4	SOUTH AFRICA	$317.8K	3.7%
5	MYANMAR	$294.7K	3.4%
6	PERU	$277.6K	3.2%
7	NETHERLANDS	$196.3K	2.3%
8	VENEZUELA	$154.4K	1.8%
9	CZECH REPUBLIC	$154.0K	1.8%
10	FRANCE	$148.5K	1.7%

UNITED KINGDOM is India's largest bisacodyl export destination, absorbing 48.4% of total exports worth $4.2M. The top 5 importing countries — UNITED KINGDOM, UNITED STATES, SRI LANKA, SOUTH AFRICA, MYANMAR — together account for 70.2% of India's total bisacodyl export value. The remaining 103 destination countries collectively receive the other 29.8%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Bisacodyl to India?

7 origin countries · Total import value: $971

India imports bisacodyl from 7 countries with a combined import value of $971. The largest supplier is GERMANY ($362, 4 shipments), followed by JAPAN and ISRAEL. All values are from Indian Customs (DGFT) import records.

Countries Supplying Bisacodyl to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$362	4	37.3%
2	JAPAN	$169	6	17.4%
3	ISRAEL	$145	1	15.0%
4	SOUTH AFRICA	$116	4	11.9%
5	NETHERLANDS	$110	3	11.3%
6	LATVIA	$55	1	5.6%
7	MALTA	$13	2	1.4%

GERMANY is the largest supplier of bisacodyl to India, accounting for 37.3% of total import value. The top 5 origin countries — GERMANY, JAPAN, ISRAEL, SOUTH AFRICA, NETHERLANDS — together supply 93.0% of India's bisacodyl imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Bisacodyl

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, bisacodyl is approved for over-the-counter (OTC) use as a stimulant laxative. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for bisacodyl products, indicating a competitive generic market. For instance, HalfLytely and Bisacodyl Tablets Bowel Prep Kit received approval on May 10, 2004. The regulatory pathway for bisacodyl involves compliance with FDA standards for OTC medications, including adherence to current Good Manufacturing Practices (cGMP) and proper labeling requirements. Given that 9.9% of India's bisacodyl exports are destined for the U.S., Indian exporters must ensure rigorous compliance with these FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, bisacodyl is regulated as an OTC medicine. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) oversee its marketing authorization. Manufacturers must comply with EU Good Manufacturing Practice (GMP) guidelines to ensure product quality and safety. In June 2025, the MHRA issued a Class 4 Medicines Defect Notification for Dulcolax Adult 5 mg Gastro-resistant Tablets due to labeling errors, underscoring the importance of accurate product information. (gov.uk) With the UK accounting for 48.4% of India's bisacodyl exports, adherence to these regulatory standards is crucial for market retention.

3WHO Essential Medicines & Global Standards

Bisacodyl is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its importance in basic healthcare systems. It is also recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), which set quality standards for its formulation and production. Compliance with these standards is essential for Indian exporters to meet international quality expectations.

4India Regulatory Classification

In India, bisacodyl is classified as an over-the-counter (OTC) medication, allowing its sale without a prescription. The Central Drugs Standard Control Organization (CDSCO) oversees its regulation. While bisacodyl is not listed under the Drug Price Control Order (DPCO) by the National Pharmaceutical Pricing Authority (NPPA), manufacturers must still comply with CDSCO guidelines for manufacturing and quality control. For exports, obtaining a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) is typically required to ensure compliance with international trade regulations.

5Patent & Exclusivity Status

Bisacodyl is a well-established pharmaceutical compound with no active patents or exclusivity rights, allowing for widespread generic production and export. This open market fosters competition among manufacturers and exporters, contributing to the significant number of active Indian exporters (240) and a diverse range of destination countries (108).

6Recent Industry Developments

In June 2025, the UK's MHRA issued a Class 4 Medicines Defect Notification for Dulcolax Adult 5 mg Gastro-resistant Tablets due to labeling errors, emphasizing the need for accurate product information. (gov.uk) Additionally, in August 2020, the MHRA introduced new measures to support the safe use of OTC stimulant laxatives, including bisacodyl, by implementing pack size restrictions and revised recommended ages for use. (gov.uk) These regulatory actions highlight the importance of compliance with labeling and safety standards for maintaining market access in the UK.

Overall, the regulatory landscape for bisacodyl involves adherence to stringent standards across major markets, including the U.S., EU, UK, and compliance with WHO guidelines. Indian exporters must ensure compliance with these regulations to sustain and expand their market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Bisacodyl

Retail & reference prices across 9 markets vs. India FOB export price of $5.76/unit

Global Price Benchmark for Bisacodyl across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.24	USD	According to the FDA's DailyMed database, Bisacodyl 5 mg tablets are available over-the-counter.
United Kingdom	$0.27	GBP	The NHS Drug Tariff lists Bisacodyl 5 mg tablets as a standard laxative available for prescription.
Germany	$0.28	EUR	Bisacodyl 5 mg tablets are included in the German Arzneimittelverzeichnis (Drug Directory) as a commonly used laxative.
Australia	$0.25

Supply Chain Risk Assessment — Bisacodyl

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Bisacodyl, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these critical components are sourced from China, underscoring a significant dependency. This reliance exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or production issues within China.

Recent analyses have highlighted that 58% of KSMs used for U.S.-approved APIs are solely sourced from a single country, predominantly China. Such concentration amplifies the risk of supply interruptions, which could adversely affect the availability and pricing of Bisacodyl in global markets.

2Supplier Concentration & Single-Source Risk

The Bisacodyl export market from India exhibits a moderate level of supplier concentration. The top five exporters account for 50.0% of the total export value, with DR. REDDY'S LABORATORIES LTD leading at a 22.9% share ($2.0 million USD). While this indicates a degree of diversification, the prominence of a single exporter introduces potential risks related to supply continuity, especially if the leading supplier faces operational challenges.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic manufacturing capabilities and reduce dependency on imports. This initiative is expected to enhance the resilience of the pharmaceutical supply chain by encouraging diversification among suppliers and promoting self-reliance in API and KSM production.

Access Complete Bisacodyl Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,294 transactions across 108 markets.

Request Demo View Pricing

Frequently Asked Questions — Bisacodyl Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top bisacodyl exporters from India?

The leading bisacodyl exporters from India are DR.REDDY'S LABORATORIES LTD, IND SWIFT LIMITED, BLISS GVS PHARMA LIMITED, and 12 others. DR.REDDY'S LABORATORIES LTD leads with 22.9% market share ($2.0M). The top 5 suppliers together control 50.0% of total export value.

What is the total export value of bisacodyl from India?

The total export value of bisacodyl from India is $8.6M, recorded across 1,294 shipments from 240 active exporters to 108 countries. The average shipment value is $6.7K.

Which countries import bisacodyl from India?

India exports bisacodyl to 108 countries. The top importing countries are UNITED KINGDOM (48.4%), UNITED STATES (9.9%), SRI LANKA (4.7%), SOUTH AFRICA (3.7%), MYANMAR (3.4%), which together account for 70.2% of total export value.

What is the HS code for bisacodyl exports from India?

The primary HS code for bisacodyl exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Bisacodyl

Bisacodyl

Top Bisacodyl Exporters from India

Top Countries Importing Bisacodyl from India

Who Supplies Bisacodyl to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Regulatory Landscape — Bisacodyl

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Bisacodyl

Supply Chain Risk Assessment — Bisacodyl

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Bisacodyl Trade Intelligence

Frequently Asked Questions — Bisacodyl Exports from India

Who are the top bisacodyl exporters from India?

What is the total export value of bisacodyl from India?

Which countries import bisacodyl from India?

What is the HS code for bisacodyl exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of bisacodyl exports from India?

Which ports handle bisacodyl exports from India?

Why is India a leading exporter of bisacodyl?

What certifications do Indian bisacodyl exporters need?

How many buyers import bisacodyl from India?

What is the market share of the top bisacodyl exporter from India?

Analysis Methodology